
|Articles|January 24, 2005
Sleep aid is first agent not limited to short-term use
Insomnia is one of the most common sleep disturbances in the United States, affecting an estimated 100 million Americans. According to the 2002 Sleep in America poll from the National Sleep Foundation, 58% of adults experience symptoms of insomnia a few nights or more per week at some point in their lives. The total economic costs associated with insomnia have been estimated at $17.5 billion.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Embedded Pharmacists Are Vital Yet Underutilized in Diabetes Care
2
The Prodigious PBM Pivot: How Supply Chain Entities Will Move Forward After CAA 2026
3
Executive Order Calls for Realignment of Childhood Vaccines
4
Pneumococcal Vaccination at 50 Years Old Can Improve Outcomes
5





























































